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ABSTRACT 
Background: Oxidative stress has been associated with tissue injury in alco- 
holic liver disease. Although this close association iswell known, whether preven- 
tion of oxidative stress retards tissue injury has not been thoroughly investigated. 
Objective: The aim of this study was to determine the effects of supplemen- 
tation with vitamins E and C on antioxidant enzyme status and histologic 
changes in hepatic tissue in a rat model of alcoholic liver disease. 
Methods: This 8-week, blinded, controlled study was conducted at the De- 
partment of Internal Medicine, Trakya University, Edirne, Turkey. Weanling 
albino female protein-deficient Wistar rats weighing -200 g were randomly 
assigned to 1 of 6 groups: (1) liquid diet + ethanol + vitamin E 15 mg/kg PO 
(LDetvitE); (2) liquid diet + ethanol + vitamin C 10 mg/kg PO (LDetvitC); (3) liq- 
uid diet + ethanol + vitamin E 15 mg/kg + vitamin C 10 mg/kg PO (LDetvitEC); 
(4) liquid diet + ethanol (LDet); (5) liquid diet + isocaloric sucrose (LDS); and 
(6) normal diet (control). The primary end point of the study was to determine 
whether antioxidant vitamin E/C combination therapy prevents development of 
hepatic fibrosis (ie, cirrhosis in a period of 1 year). After being euthanized at 
week 8, the rats were weighed, and their livers and spleens were weighed. 
Hepatic tissue specimens were histopathologically assessed according to the 
Brunt system. Hepatic tissue glutathione peroxidase, superoxide dismutase, 
and catalase activities were determined. Biochemical tissue collagen concentra- 
tions were measured to determine the presence of hepatic fibrosis. 
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Results: Seventy-two rats were included in the study (mean [SE] weight, 205 
[21] g) (12 rats per group). Initially planned to last 48 weeks, the study was ter- 
minated at 8 weeks due to the death of 3 rats in each group (except he LDS 
group and control group). The relative liver weight was significantly lower in 
the LDetvitEC group compared with that in the LDet group (mean [SE], 3.7% 
[0.5%] vs 4.8% [0.9%]; P < 0.01). Mean (SE) hepatic tissue glutathione peroxi- 
dase activity was significantly reduced in the LDet-treated rats compared with 
controls (1.2 [0.2] vs 2.6 [0.3] U/mg protein; P< 0.001). The groups that received 
supplementation with vitamin E, vitamin C, and vitamins E and C combined had 
significantly more hepatic glutathione peroxidase activity (mean [SE], 2.1 [0.5], 
2.5 [0.2], and 2.6 [0.7] U/mg protein, respectively) compared with the LDet 
group (1.2 [0.2] U/mg protein) (all, P < 0.001). No significant between-group dif- 
ferences in hepatic superoxide dismutase or catalase activities were found. 
Compared with controls (14.5 [1.9] 1Jg collagen/mg protein), the mean (SE) his- 
tologic hepatic collagen concentration was significantly higher in all groups 
(19.2 [1.2], 19.5 [3.3], 18.5 [3.0], 25.9 [3.3], and 21.6 [1.5] 1Jg collagen/mg protein 
in the LDetvitE, LDetvitC, LDetvitEC, LDet, and LDS groups, respectively; P < 
0.01, P< 0.01, P< 0.05, P< 0.001, and P< 0.001, respectively). Compared with the 
LDet group, the mean hepatic ollagen concentration was significantly ower in 
the LDetvitE, LDetvitC, and LDetvitEC groups (P < 0.01, P < 0.05, and P < 0.01, 
respectively). The LDetvitEC group had a significantly ower mean (SE) hepatic 
inflammatory score compared with the LDet group (0.8 [0.1] vs 1.3 [0.2]; P < 
0.05). The LDetvitEC group had a significantly lower mean (SE) hepatic necro- 
sis score compared with that in the LDet group (1.5 [0.2] vs 2.4 [0.3]; P< 0.05). 
Conclusions: The results of this study in protein-deficient rats fed with a 
high-fat liquid diet suggest that supplementation with vitamin E, vitamin C, and 
a combination of vitamins E and C was associated with decreased ethanol- 
induced hepatic glutathione peroxidase activity and hepatic fibrosis, and that 
supplementation with vitamins E and C might have attenuated the development 
of hepatomegaly and hepatic necroinflammation, whereas this result was not 
found in the group given a liquid diet and ethanol in this 8-week study. (Curr 
Ther Res Clm Exp. 2006;67:118-137) Copyright © 2006 Excerpta Medica, Inc. 
Key words: alcohol, necrosis, inflammation, fibrosis, vitamin E, vitamin C, 
glutathione peroxidase. 
INTRODUCTION 
Underlying mechanisms for the development of hepatic fibrosis in alcoholic 
liver disease have not been thoroughly reported. Although the presence of 
oxidative stress is well known in alcoholic liver disease, whether it contributes 
to progressive hepatic fibrosis, resulting in cirrhosis, is debatable. 1 Anti- 
oxidants are currently not recommended in the treatment of patients with alco- 
holic liver disease. 2 Studies performed to demonstrate the effectiveness of
antioxidant therapies on prevention or treatment of alcoholic liver disease are 
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not sufficient. In 2 clinical studies with population umbers of 25 and 67, respec- 
tively, patients with alcoholic hepatitis were evaluated for 3 and 12 months, 
respectively. 3,4In these controlled studies, vitamin E supplementation did not 
provide improvement of hepatic laboratory parameters, mortality, or hospitaliza- 
tion rates of decompensated alcoholic irrhotics. However, these patients did not 
take vitamins before the initiation of alcohol consumption and no histopathologic 
examinations were performed before or after the study period. 
The liver is rich in antioxidant enzymes (eg, glutathione peroxidase, super- 
oxide dismutase, catalase) that can metabolize reactive oxygen species. 5 
Antioxidant enzymes eliminate superoxide anions and hydroperoxides that can 
oxidize cellular substrates. However, these enzymes also exert protective f- 
fects by scavenging the oxidized forms of the nonenzymatic antioxidants vita- 
min E, vitamin C, and glutathione. 6 In a study in a rat model by Schisler and 
Singh, 7 rats given ethanol (4 rats at 5% ethanol; 4 rats at 15% ethanol) for 14 days 
had decreased mean (SE) hepatic activities of total glutathione peroxidase 
(0.38 [0.04] 1Jmol • mg/min protein; P < 0.05) and superoxide dismutase (0.43 
[0.02] U/mg protein; P < 0.05) compared with those of matched controls (17.36 
[1.50] and 0.71 [0.06], respectively). Hepatic catalase activity was not affected 
by chronic ethanol treatment in rats. 
Vitamin E deficiency might be one of several factors causing oxidative stress 
in alcoholic liver disease. Studies in alcoholic patients 8 and in rats fed ethanol 9,1° 
have found significantly reduced vitamin E concentrations in serum and hepatic 
tissue. In the study by Bjorneboe t al, 8 the effect of heavy alcohol consumption 
on serum concentrations of vitamin E was studied in 13 alcoholics and 19 con- 
trol subjects. Of the 13 alcoholics, 6 had a serum concentration of ~-tocopherol 
below the lower limit of reference (14 1Jmol/L) and mean serum concentration 
of ~-tocopherol was reduced by 37% compared with controls (P < 0.002). The 
effects of chronic ethanol feeding (3 weeks) on hepatic lipid peroxidation and 
vitamin E levels were investigated in the rats fed low or adequate amounts of 
dietary vitamin E. 1° Hepatic lipid peroxidation was significantly increased after 
chronic ethanol consumption i rats receiving a low-vitamin E diet. This indi- 
cated that dietary vitamin E is an important determinant of hepatic lipid peroxi- 
dation induced by chronic ethanol feeding. Low dietary vitamin E and ethanol 
consumption significantly reduced hepatic ~-tocopherol content, and the low- 
est hepatic ~-tocopherol was found in the rats receiving a combination of low 
vitamin E and ethanol. Furthermore, thanol consumption caused a marked 
increase of hepatic ~-tocopheryl quinone, a metabolite of ~-tocopherol by free 
radical reactions. Therefore, ethanol consumption causes a marked alteration 
of vitamin E metabolism in the liver and the combination of ethanol consump- 
tion with a low-vitamin E intake results in a decrease of hepatic ~-tocopherol 
content, which renders the liver more susceptible to free radical attack. The 
reduction in vitamin E concentration might have been due to malabsorption 
and low intake. 1° In a separate study in a rat model by Odeleye t al, 11 vitamin E 
supplementation was associated with normalized (hepatic tissue vitamin E 
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levels in nmol/g wet liver [SE]: normal rats, 143.74 [19.85]; ethanol group, 89.66 
[14.32]; ethanol + vitamin E, 118.62 [27.93] [no statistical difference between 
normal and ethanol + vitamin E group]) vitamin E concentration i  (n = 5 rats 
per group) ethanol-fed rats. 
The present study used vitamin E because it is the primary fat-soluble, chain- 
breaking antioxidant that protects lipid bilayers in the liver. 6 We also studied 
another antioxidant, vitamin C, which plays a scavenger role, particularly in 
plasma, cytosol, and other aqueous compartments. 12 Supplementation with a 
combination of vitamins E and C might result in a synergistic effect by deoxidizing 
and regenerating vitamin E. 13'14 The present study aimed to investigate the effects 
of enzymatic antioxidant defense systems and their response to supplementation 
with vitamins E and/or C in alcoholic hepatic injury in protein-deficient rats. 
MATERIALS AND METHODS 
This 8-week, blinded, controlled study was conducted at the Department of 
Internal Medicine, Trakya University, Edirne, Turkey. The study protocol was 
approved by the ethics committee of the medical faculty at the university. 
Animals and Diet 
Weanling albino female protein-deficient Wistar rats weighing -200 g were 
housed in cages with stainless teel wire tops and 12-hour light-dark cycles at 
a mean (SD) ambient temperature of 21°C (1°C) and a mean (SD) humidity of 55% 
(5%). Rats were labeled with numbers, and corresponding numbers were 
picked from a box by a blinded member of the study team, randomly assign- 
ing the rats to 1 of 6 groups: (1) liquid diet + ethanol + vitamin E 15 mg/kg 
PO (LDetvitE)*; (2) liquid diet + ethanol + vitamin C 10 mg/kg PO (LDetvitC)T; 
(3) liquid diet + ethanol + vitamin E 15 mg/kg + vitamin C 10 mg/kg PO 
(LDetvitEC); (4) liquid diet + ethanol (LDet); (5) liquid diet + isocaloric sucrose 
(LDS); and (6) normal diet (control). 
The daily dose (15 mg/kg) of vitamin E selected, previously used by Montilla 
et al, 15 was considerably higher than the normal daily needs of rats established 
by the National Research Council 16 (18 mg/kg). Normally, rats do not require a 
dietary source of vitamin C. Enzymatic synthesis of this vitamin can occur via glu- 
curonolactone or gluconolactone in the rat liver. Ascorbic acid might help pro- 
tect against peroxidation and spare vitamin E. It has been found to decrease 
expired pentane, used as a marker for lipid peroxidation. 17 Administration of 
vitamins E and C was started on the first day of the study. 
To develop a model of established alcoholic irrhosis, the rats were fed a liq- 
uid diet, the content of which was similar to that of alcoholic patients--severely 
deficient in protein and rich in fat (principally comprising a combination of 
*Trademark: Evigen ® (Aksu Farma, Istanbul, Turkey). 
tTrademark: Redoxon ® (Roche MOstahzarlan Sanayi S.A., Istanbul, Turkey). 
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mashed potatoes and mayonnaise), providing sufficient calories (38% of total 
calories from fat, 37% from ethanol, 22% from complex carbohydrates, and 3% 
from protein), and mixed with ethanol to produce alcoholic liver disease--as pre- 
viously described by Bosma et al. 18 The diet was prepared aily (by A.R.S. and 
U.N.B. with fresh food and ingredients) in a kitchen by mixing all of the ingredients 
using a kitchen mixer. The rats in the control group had free access to standard rat 
chow and water. All of the groups were fed their particular diets ad libitum. 
This study was initially designed to last 48 weeks but was terminated early (at 
week 8) due to death in some of the animals. At the end of the study, the rats were 
weighed and euthanized. The liver and spleen of each rat were also weighed. 
Hepatomegaly was defined as liver wet weight of >3 g per 100 g rat body weight. 19 
Hepatic Tissue Sampling 
The left, middle, and right lobes of each liver were explored by a nonblinded 
investigator (U.N.B.); 1.5 cm 3 of tissue was randomly sampled from one of six 10 x 
5 x 5 mm slices of liver (ie, 1 slice from the anterior and distal ends of each of the 
3 hepatic lobes). Each slice was cut in half, so that it measured 5 x 5 x 5 mm. One 
half of each slice was stored for 3 months at -86°C and was subsequently used to 
determine tissue superoxide dismutase, catalase, and glutathione peroxidase activ- 
ities. The other half of each slice was fixed in 10% buffered formalin. The paraffin 
embedding was preceded by dehydration and clearing. First, water from the tissues 
was removed by dehydration, done with a graded series of ethanol:water (70% 
to 100% ethanol) mixtures. The ethanol was then replaced by the solvent xylene 
miscible with embedding medium (paraffin). The cleared fragments were blocked 
into paraffin for subsequent biochemical analysis to detect collagen concentration. 
Tissue Antioxidant Enzyme Activities 
All enzyme activities were determined after hepatic tissue was homogenized 
with phosphate-buffered saline at a pH of 7.4. Total (copper-zinc and manga- 
nese) superoxide dismutase activity was determined according to the method 
of Sun eta],  2° which is based on the inhibition of nitroblue tetrazolium (NBT) 
reduction by the xanthine-xanthine oxidase system as a superoxide generator. 
One unit of superoxide dismutase was defined as the amount of enzyme needed 
to achieve 50% inhibition in the NBT reduction rate. The specific activity was 
expressed in units per milligram of protein. The catalase activity was measured 
according to Aebi21; a method based on the determination of the rate constant 
(k/s) of hydrogen peroxide decomposit ion rate at 240 nm. The results were 
expressed as the rate constant per milligram homogenate protein. Glutathione 
peroxidase activity was measured according to Lawrence and Burk, 22 by moni- 
toring the oxidation of reduced nicotinamide adenine dinucleotide phosphate 
hydrogen (NADPH) at 340 nm. Enzyme units were expressed as the number of 
micromoles of NADPH oxidized per minute and calculated using the extinction 
coefficient of NADPH at 340 nm (6.22 x 10 -3 mol • cm/L). Results were report- 
ed as units per milligram of protein. The protein content of tissue samples was 
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determined by the method of Lowry et al, 23 using bovine albumin as the standard. 
The investigators (N.A. and K.K.) who measured enzyme activity were blinded 
to treatment assignment. 
Biochemical Hepatic Collagen Concentration Determination 
Hepatic collagen concentration was assayed using the colorimetric method 
described by Lopez-De Leon and Rojkind. 24 Collagenous protein was stained using 
Sirius red (36554-8, 2610-10-8; Aldrich Chemical, Deisenhofen, Germany) and non- 
collagenous proteins were stained using fast green (14280; Merck KGaA, 
Darmstadt, Germany). Liver slices 15 1Jm thick were taken from each paraffin block 
and layered on glass slides. The paraffin was removed from the slices after incuba- 
tion with xylol, xylol:ethanol (1:1), ethanol, water:ethanol, and water. The slides 
were stained with a saturated solution of picric acid in distilled water containing 
0.01% fast green. The sections were not exposed to light and were incubated at 
room temperature (20°C) for 15 minutes. They were rinsed until the eluent was 
free of color. They were then stained with a saturated solution of picric acid in dis- 
tilled water containing 0.04% fast green and 0.1% Sirius red and incubated in the 
dark at room temperature (20°C) for 30 minutes. The samples were rinsed and 
transferred to a test tube containing 1 mL of 0.1% sodium hydroxide in absolute 
methanol (1:1). The tubes were gently mixed until the color was completely eluted. 
Absorbance of the eluted color was read using a spectrophotometer (V-50 UV-VIS, 
Jasco Inc., Easton, Maryland) at 540 and 630 nm. 
Maximum absorbance of fast green occurs at 630 nm and Sirius red at 540 nm. 
Fast green exhibits a small absorbance (7.78%) at 540 nm. This percentage of
interference remains constant despite concentration. Because Sirius red has 
no absorbance at 630 nm, it does not interfere with noncollagenous protein 
determination.24, 5 
Collagen content was calculated using the following formulas25: 
Collagen (1Jg)/Total protein (mg) = Collagen (1Jg)/(Collagen [mg] + 
Noncollagenous protein [mg]) 
Collagen (mg) = ([Absorbance at 540 nm (%) - 7.78%] + 
Absorbance at 630 nm [%])/37 
Noncollagenous protein (mg) = Absorbance at 630 nm (%)/3 
where 37 and 3 were determined as color equivalences per milligram of Fast 
green and Sirius red, respectively. 
The investigators (O.T. and N.G.) were blinded to treatment assignment while 
measuring collagen concentration. 
Histopathologic Examination 
Necroinflammatory activity grading and fibrosis staging were determined 
using the Brunt system (Table ~).26 The pathologists (S.A. and K.K.) were blinded 
to treatment assignment while reading the results. 
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Statistical Analysis 
Data were expressed as mean (SE). The Shapiro-Wilks test was used to assess 
the normality of continuous data. For all variables, the statistical differences 
between groups were tested using 1-way analysis of variance for normally dis- 
tributed data (relative liver, spleen, and body weights and glutathione peroxi- 
dase, superoxide dismutase, and catalase activities). The nonparametric 
Kruskal-Wallis test was used for nonnormally distributed ata (biochemical 
hepatic collagen concentration, inflammatory activities, necrosis grade, and 
fibrosis stage). 27 Multiple comparisons were made using the Tukey post hoc 
multiple comparisons test for normally distributed ata, and the nonparamet- 
ric Tukey post hoc multiple comparisons test for nonnormally distributed 
data. 28 Statistical analysis was performed with SPSS version 11.0 (SPSS Inc., 
Chicago, Illinois). P ( 0.05 was considered statistically significant. A power of 
the study analysis was not made. 
RESULTS 
Seventy-two rats were included (mean [SE] weight, 205 [21] g) (12 rats per 
group). Three rats in each group (except he LDS group and control group) died 
from empyema nd/or deep neck infection, as confirmed on autopsy, before 
week 8 and were excluded from the analysis. Because of these deaths, the study 
was shortened from the intended 48 weeks to 8 weeks. 
Although body weight was statistically similar between all treatment groups at 
the beginning of the study, the rats in the LDet group weighed significantly less 
than those in the control group at 8 weeks (mean [SE], 169 [28] vs 231 [32] g, 
respectively; P < 0.001) (Table II). When we compare baseline body weights with 
week 8 and those who were excluded from the analysis, only the control group 
showed a statistically significant weight gain compared with baseline (P < 0.01) 
and only the LDet group lost weight compared with baseline (P < 0.05) (Wilcoxon 
2-related samples test). 
Significant differences in regard to relative liver weight were only present 
between the LDet group and the control group (4.8% [0.9%] vs 3.6% [0.3%]; P< 
0.01) and between the LDet group and the LDetvitEC group (4.8% [0.9%] vs 4.1% 
[0.6%]; P< 0.01). Mean relative spleen weights were statistically similar between 
all 6 study groups. 
On microscopic examination ofthe liver sections, hyperemia, cellular swelling, 
sinusoidal dilatation, and necrosis were found in the LDet group (Figure 1A--C). 
In the rats administered LDetvitEC, cellular damage was less compared with that 
in the LDet group or absent (Figure 1D-I 0. 
The groups treated with vitamin supplementation had significantly more glu- 
tathione peroxidase activity compared with that in the LDet group (mean [SE], 
2.1 [0.5], 2.5 [0.2], and 2.6 [0.7] U/mg protein in the LDetvitE, LDetvitC, and 
LDetvitEC groups, respectively, vs 1.2 [0.2] U/mg protein in the LDet group; all, 
P < 0.001) (Table III and Figure 2). Hepatic tissue glutathione peroxidase activ- 
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Figure 1. Histologic changes in rats receiving ethanol without supplementation with 
vitamin E or C, showing (A) widespread hepatic necrosis, (B) hydropic de- 
generation of hepatocytes, and (C) sinusoidal dilatation. Preservation of 
hepatic structure in rats administered combined vitamins E and C supple- 
mentation, showing (D) no necrosis or (E, F) hydropic degeneration. (Hema- 
toxylin and eosin; magnification, x100 [A, B, D, E] or x200 [C, F].) 
ity was significantly less in the LDet group compared with that in the control 
group (mean [SE], 1.2 [0.2] vs 2.6 [0.3] U/mg protein; P < 0.001). No significant 
differences in hepatic tissue superoxide dismutase or catalase nzyme activi- 
ties were found between any of the groups (Table III). 
The mean (SE) hepatic collagen concentrations were significantly higher in 
the LDetvitE, LDetvitC, LDetvitEC, LDet, and LDS groups compared with that 
in the control group (19.2 [1.2], 19.5 [3.3], 18.5 [3.0], 25.9 [3.3], and 21.6 
[1.5] 1Jg/mg protein, respectively, vs 14.5 [1.9] 1Jg/mg protein; P< 0.01, P< 0.01, P< 
0.05, P < 0.001, P < 0.001, respectively) (Table III and Figure 3). Despite having 
higher hepatic ollagen concentrations when compared with that of the control 
group, the LDetvitE, LDetvitC, and LDetvitEC groups had significantly (25%) 
lower hepatic collagen concentrations compared with the LDet group as mea- 
sured using the biochemical method (P < 0.01, P < 0.05, and P < 0.01, respec- 
tively). No statistically significant differences in mean hepatic total biochemical 
collagen concentrations were found between the groups treated with vitamin 
supplementation. 
The histologic inflammation score was found to be significantly ower in the 
LDetvitEC group when compared with those in the LDetvitE, LDetvitC, and LDet 
groups (0.8 [0.1] vs 1.5 [0.2], 1.4 [0.2], and 1.3 [0.2], respectively; all, P< 0.05) 
(Table IV). The mean (SE) necrosis score was significantly lower in the 
LDetvitEC group compared with the LDet group (P < 0.05). Differences in fibro- 
sis scores were not statistically significant between any of the groups. 
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Figure 2. Glutathione peroxidase activity in each t reatment  group. LDetvitE = liquid 
diet + ethanol + vitamin E 15 mg/kg PO; LDetvitC = liquid diet + ethanol + 
vitamin C 10 mg/kg PO; LDetvitEC = liquid diet + ethanol + vitamin E 15 mg/kg 
+ vitamin C 10 mg/kg PO; LDet = liquid diet + ethanol; LDS = liquid diet + 
isocaloric sucrose. *P < 0.001 versus LDet; tp < 0.001 versus control; ~P < 0.01 
versus control (all comparisons; nonparametr ic  Tukey test). 
DISCUSSION 
The results of this study in a rat model suggest hat long-term ethanol adminis- 
tration reduced glutathione peroxidase activity in rats with severe malnutrition. 
Supplementation with vitamins E and/or C was associated with attenuation ofthe 
ethanol-induced decrease in hepatic glutathione peroxidase activity (LDetvitE 
and LDetvitC groups, P < 0.001 vs LDet group), decreased hepatocellular inflam- 
mation (LDetvitE and LDetvitC groups, P < 0.05 vs the control group) and necro- 
sis (LDetvitE and LDetvitC groups, P < 0.05 and P < 0.01 vs the control group, 
respectively), retardation of alcoholic fibrosis (as demonstrated by biochemical 
liver collagen content determination), and reduced hepatomegaly (LDetvitEC, P< 
0.01 vs LDet)--the most common clinical manifestation of alcoholic liver disease. 
Body weight loss was not found in the groups receiving vitamin E and/or C. 
Hepatic metabolism of ethanol inherently produces reactive oxygen species, 
including superoxide anion, hydroxyethyl, and hydroxyl radicals. 5 Free radicals 
can damage a variety of intracellular compounds by attacking unsaturated 
lipids in cellular membranes, and can initiate a lipid peroxidation chain reac- 
tion. Membrane fluidity increases, and calcium homeostasis  disturbed, lead- 
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Figure 3. Effects of treatments on hepatic collagen concentration of malnourished 
rats measured using a biochemical method. LDetvitE = liquid diet + ethanol + 
vitamin E 15 mg/kg PO; LDetvitC = liquid diet + ethanol + vitamin C 10 mg/kg 
PO; LDetvitEC = l iquid diet  + ethanol  + v i tamin  E 15 mg/kg  + v i tamin  C 
10 mg/kg PO; LDet = liquid diet + ethanol; LDS = liquid diet + isocaloric 
sucrose. *P < 0.01 versus control; tp < 0.01 versus LDet; ~P < 0.05 versus 
LDet; §P < 0.05 versus control; lip < 0.05 versus LDS; Ip  < 0.001 versus con- 
trol  (all comparisons; nonparametr ic Tukey test). 
ing to cellular necrosis and cellular death. 29 Glutathione peroxidase provides a 
second line of defense to destroy the peroxides before they damage membranes. 5 
The effects of free radicals on the liver might be amplified when ethanol reduces 
antioxidant defenses. In a study of a pig model of alcoholic liver disease by 
Zindenberg-Cherr et al, 3° a decrease in glutathione peroxidase activity was seen 
and might have been related to the effect of free radicals in inactivating lu- 
tathione peroxidase. In our study, superoxide dismutase and catalase activities 
were not significantly altered, but glutathione peroxidase activity was pre- 
vented to decrease in 3 of the groups given vitamin supplementat ion compared 
with the LDet group (LDetvitE, LDetvitC, and LDetvitEC, P < 0.001 vs LDet). 
Hyperemia, cellular swelling, sinusoidal dilatation, and necrosis were observed 
in the livers of ethanol-fed rats and were likely associated with impaired glu- 
tathione peroxidase activity. Compared with LDet, supplementat ion with com- 
bined vitamins E and C was associated with normalized glutathione peroxidase 
activity and attenuation of hepatocellular inflammation and necrosis (P < 0.05, 
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P< 0.05, and P< 0.05, respectively). The administration of ethanol, vitamin E, or 
vitamin C was not associated with changes in catalase and superoxide dismu- 
tase activities. Whether this unaltered enzyme activity stemmed from the effect 
of the liquid diet needs to be clarified. 
Hepatic fibrosis is a highly integrated cellular response to t issue injury 
induced by various factors (eg, viruses, autoimmune activity, metabolism, alcohol 
ingestion). 31 Activated perisinusoidal hepatic stellate cells become myofibroblast- 
like and secrete xcessive type I collagen, the major extracellular matrix protein 
deposited in hepatic tissue during fibrogenesis. 32Alcohol intake might contribute 
to stellate cell activation in several ways. Elevated hepatic malondialdehyde 
concentrat ion might contr ibute to hepatic fibrosis by directly inducing colla- 
gen secretion from stellate cells by reduction-oxidation-sensit ive transcription 
factors (eg, activator protein-1 and nuclear factor-•B), and paracrine stimula- 
tion of stellate cells through the release of transforming rowth factor (TGF)-[3 
from Kupffer cells. 33-35 Vitamin E supplementat ion has been associated with 
the inhibition of lipid peroxide- induced collagen synthesis  in cultured fibro- 
blasts and stel late cells. 36,37 It is suggested that this inhibition was caused by 
decreased fibrogenic ytokine TGF-[3 concentrat ions.  36 In our study, no signif- 
icant differences in hepatic total biochemical collagen concentrat ions were 
found between the groups treated with vitamin supplementat ion on light mi- 
croscopy, suggesting that combination therapy with vitamins E and C was as 
effective as vitamin E or vitamin C administered alone in reducing hepatic fibro- 
sis. However, we also measured collagen concentrat ion using a biochemical 
method more sensitive than microscopy; that method found that supplementa- 
tion with vitamins C and E was accompanied by a significant reduction in colla- 
gen concentration (LDetvitE, LDetvitC, and LDetvitEC groups, P < 0.01, P < 0.05, 
and P< 0.01 vs LDet group, respectively; P< 0.01, P< 0.01, and P< 0.05 vs con- 
trois, respectively). These findings suggest hat preventing a decrease in anti- 
oxidant enzyme activity results in decreased hepatic fibrosis. Vitamin E acetate 
was not found to accumulate at crucial sites of cell injury, such as the mitochon- 
dria, or to partition into organelle phosphol ipid bilayers. 38 However, vitamin C 
is thought o regenerate vitamin E, 13'14 possibly allowing for its accumulation at 
crucial sites. 
In a search of English-language literature concerning the use of vitamins E 
and C in alcoholic liver disease using MEDLINE (key terms: vitamin E, vitamin C, 
ethanol and hepatic fibrosis; years: 1967-2005), we found only 2 long-term experi- 
mental studies in which the effects of vitamin E supplementat ion  alcoholic 
liver disease were assessed. In a study by Nanji et al, 39 10 rats were fed fish oil 
and ethanol for 6 weeks. At the end of week 6, ethanol treatment was discontin- 
ued and vitamin E treatment was started in 5 rats. Vitamin E was associated 
with decreased necroinflammation (30 cells/mm 2 vs 15.7 cells/mm2; P < 0.05) 
and improved lipid peroxidation (thiobarbituric acid reactive substances level 
0.74 [0.19] nmol/mg protein vs 0.30 [0.11] nmol/mg protein; P < 0.01) com- 
pared to those rats not administered vitamin E (n = 5). Our findings were consis- 
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tent with those of Nanji et al. However, in a s tudy  by Sadrzadeh et al, 4° 
although high-dose vitamin E supplementat ion was associated with decreased 
lipid peroxidation, it was not associated with decreased severity of tissue 
injury. In that study, rats were administered 1200-fold the normal amount of 
required vitamin E, and whether that high dose contr ibuted to the failure of 
vitamin E to improve hepatic injury is unclear. Furthermore, the findings from 
Sadrzadeh et al might be misleading because hepatic fibrosis was assessed 
using only light microscopy, which is not a sensitive method. Light microscopy 
is not sensitive enough to quantify or compare subtle fibrotic changes in the 
liver, especially in alcoholic liver disease models based on such a short  period 
of time, as is the case of both the Sadrzadeh et al study and ours. This is primar- 
ily due to the short  time period of the study; 2 months is an inadequate amount 
of time for significant changes to be established and observed. Therefore, we 
used a more sophist icated and sensitive method to compare the hepatic fibro- 
sis (ie, the determination of collagen content by biochemical method). 41,42 Ac- 
cording to the results found with this method, antioxidants effectively reduced 
hepatic fibrosis in this rat model of alcoholic liver disease. 
In a separate study in a rat model of acute ethanol- induced hepatic damage, 
Ozdil et a143 found that the use of combined supplementat ion with vitamin E, 
vitamin C, and selenium was associated with decreased egenerative changes 
observed on light and electron microscopy. In human studies, 44,45 the efficacy of 
combined supplementat ion with vitamins E and C has been reported in nonal- 
coholic steatohepatit is (NASH), which is histopathological ly similar to alcohol- 
related hepatitis. In the study by Yakaryilmaz et al, 45 16 patients with NASH were 
given vitamin E 800 U/day in 2 divided doses for 6 months. Significant improve- 
ments in mean (SD) serum liver enzyme activities were observed at 6 months 
compared with baseline. Posttreatment liver biopsy was available in 13 patients 
(81%). Significant improvements in the mean (SD) scores of steatosis (1.46 
[0.66] vs 2.43 [0.62]; P = 0.002) and necroinf lammatory grade (0.84 [0.24] vs 1.31 
[0.51]; P = 0.006) were observed at 6 months compared with baseline, respec- 
tively. However, no significant change was noted in the mean (SD) score of fibro- 
sis stage (0.77 [0.33] vs 1.12 [0.59], respectively). In the second study, which 
was a prospective, double-blind, randomized, placebo-control led trial by 
Harrison et al, 44 45 patients were randomized to receive either vitamins E and C 
(1000 IU and 1000 mg, respectively) or placebo QD for 6 months. Vitamin treat- 
ment resulted in a statistically significant improvement in fibrosis score (P = 
0.002). However, they observed no changes in inflammation with treatment. In 
our study, in contrast  to patients with NASH in the study by Harrison et al, 
necroinflammation was reduced by combined vitamins E and C therapy. The dif- 
ferent study designs (humans vs rats) and different diseases (NASH vs alcoholic 
liver disease) may not explain the controversy between these 2 studies. 
However, improvement in hepatomegaly observed only in the combination 
group (LDetvitEC) compared with the LDet group (P < 0.01), in association with 
the improvement of necroinflammation i  the liver, suggests that combining 
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antioxidants might increase the therapeutic effects of each on alcoholic liver 
disease. 
We used the liquid diet described by Bosma et a118 to simulate the diet of alco- 
holic patients to achieve an alcoholic cirrhosis model in rats. However, when we 
used that diet, the rats began to die during the second month of the study due 
to empyema nd deep neck infections related to severe cachexia and malnutri- 
tion. Hence, we decided to terminate the study and euthanize the rats at 8 weeks, 
before the predetermined time period of 48 weeks. The rats used in the study by 
Bosma et al did not die earlier than expected, possibly because they used a dif- 
ferent species of rats than the ones we used, and because the rats were kept in 
aseptic conditions from birth. Despite its short duration of 8 weeks, ours is the 
longest-term animal study of the antioxidant effects of vitamins E and C on alco- 
holic hepatic injury in a rat model based on our MEDLINE search. 
In our study, necroinflammation a d fibrosis were similar between rats in the 
LDet and LDS groups, suggesting that the damage might have been associated 
with the high-fat, protein-deficient liquid diet. However, none of the rats in the 
LDS group died earlier than expected, in contrast o those in the LDet group. 
Hepatomegaly, an important clinical finding in alcoholic liver disease, was 
observed in the LDet group but not in the LDS group. Nonetheless, the addition 
of a group fed normal diet and ethanol might have allowed for a better compar- 
ison of the impact of ethanol on tissue injury. The effects of diet, malnutrition, 
sex, and genetics on tissue damage in the pathogenesis of alcoholic liver dis- 
ease still need to be studied. 
CONCLUSIONS 
The results of this study in protein-deficient rats fed with a high-fat liquid diet 
suggest hat supplementat ion with vitamin E, vitamin C, and a combination of 
vitamins E and C was associated with decreased ethanol- induced hepatic glu- 
tathione peroxidase activity and hepatic fibrosis, and that supplementat ion 
with vitamins E and C might have attenuated the development of hepatomegaly 
and hepatic necroinflammation, whereas this result was not found in the group 
given a liquid diet and ethanol in this 8-week study. 
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